<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://darebioscience.com/role/Acquisitions" xlink:href="dare-20190331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/AcquisitionsAdditionalInformationDetail" xlink:href="dare-20190331.xsd#AcquisitionsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/AcquisitionsScheduleOfPurchasePriceConsiderationAllocationDetail" xlink:href="dare-20190331.xsd#AcquisitionsScheduleOfPurchasePriceConsiderationAllocationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/AcquisitionsTables" xlink:href="dare-20190331.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsAndContingencies" xlink:href="dare-20190331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="dare-20190331.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:href="dare-20190331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="dare-20190331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="dare-20190331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="dare-20190331.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="dare-20190331.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/DocumentAndEntityInformation" xlink:href="dare-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GoingConcern" xlink:href="dare-20190331.xsd#GoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GoingConcernAdditionalInformationDetail" xlink:href="dare-20190331.xsd#GoingConcernAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAward" xlink:href="dare-20190331.xsd#GrantAward" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/GrantAwardAdditionalInformationDetail" xlink:href="dare-20190331.xsd#GrantAwardAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedProperties" xlink:href="dare-20190331.xsd#LeasedProperties" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesDetails" xlink:href="dare-20190331.xsd#LeasedPropertiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesLeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:href="dare-20190331.xsd#LeasedPropertiesLeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/LeasedPropertiesTables" xlink:href="dare-20190331.xsd#LeasedPropertiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerShare" xlink:href="dare-20190331.xsd#NetLossPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetail" xlink:href="dare-20190331.xsd#NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/NetLossPerShareTables" xlink:href="dare-20190331.xsd#NetLossPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="dare-20190331.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/OrganizationAndDescriptionOfBusinessAdditionalInformationDetail" xlink:href="dare-20190331.xsd#OrganizationAndDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensation" xlink:href="dare-20190331.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:href="dare-20190331.xsd#StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesOptionPricingModelForStockOptionsGrantedToEmployeesAndDirectorsDetail" xlink:href="dare-20190331.xsd#StockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesOptionPricingModelForStockOptionsGrantedToEmployeesAndDirectorsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpenseRelatedToStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:href="dare-20190331.xsd#StockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpenseRelatedToStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationSummaryOfStockOptionActivityForAmended2014PlanAndRelatedInformationDetail" xlink:href="dare-20190331.xsd#StockBasedCompensationSummaryOfStockOptionActivityForAmended2014PlanAndRelatedInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockBasedCompensationTables" xlink:href="dare-20190331.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquity" xlink:href="dare-20190331.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetail" xlink:href="dare-20190331.xsd#StockholdersEquityAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityScheduleOfCommonStockWarrantsOutstandingDetails" xlink:href="dare-20190331.xsd#StockholdersEquityScheduleOfCommonStockWarrantsOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/StockholdersEquityTables" xlink:href="dare-20190331.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SubsequentEvents" xlink:href="dare-20190331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SubsequentEventsDetails" xlink:href="dare-20190331.xsd#SubsequentEventsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="dare-20190331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="dare-20190331.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="dare-20190331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://darebioscience.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3DBB3FEB7B3AADB7790A5B0CFD617E81" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8AD112719732F8A08E325B0CFD6148C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3DBB3FEB7B3AADB7790A5B0CFD617E81" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8AD112719732F8A08E325B0CFD6148C9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AcquisitionsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_40DA05A766B89B649EC7988EB36C9A7E" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ScheduleOfBusinessCombinationReverseMergerTable" xlink:label="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_645B69D56C766E61C186988EB36D30AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_40DA05A766B89B649EC7988EB36C9A7E" xlink:to="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_645B69D56C766E61C186988EB36D30AC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_AC59DB811D6437EBFD98988EB36DECD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_645B69D56C766E61C186988EB36D30AC" xlink:to="loc_dei_LegalEntityAxis_AC59DB811D6437EBFD98988EB36DECD6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_C46089FD10A5057C047E988EB36D6441" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_AC59DB811D6437EBFD98988EB36DECD6" xlink:to="loc_dei_EntityDomain_C46089FD10A5057C047E988EB36D6441" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PrivateDareMember" xlink:label="loc_dare_PrivateDareMember_DFED8E4F3B4F936FB800988EB36D3330" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_C46089FD10A5057C047E988EB36D6441" xlink:to="loc_dare_PrivateDareMember_DFED8E4F3B4F936FB800988EB36D3330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3864F8EA69C4B78CF526988EB36E8529" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_645B69D56C766E61C186988EB36D30AC" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3864F8EA69C4B78CF526988EB36E8529" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_175D11F404BBC458915C988EB36E3CCD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3864F8EA69C4B78CF526988EB36E8529" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_175D11F404BBC458915C988EB36E3CCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_04852BF7BED96F142A60988EB36E859B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_175D11F404BBC458915C988EB36E3CCD" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_04852BF7BED96F142A60988EB36E859B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_B3A2A26371D6C381760E988EB36F5580" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_175D11F404BBC458915C988EB36E3CCD" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_B3A2A26371D6C381760E988EB36F5580" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_AE5555FF93BB0183415A988EB36F51C6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_645B69D56C766E61C186988EB36D30AC" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_AE5555FF93BB0183415A988EB36F51C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4A340493B2421FB3C53B988EB3743BBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_AE5555FF93BB0183415A988EB36F51C6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4A340493B2421FB3C53B988EB3743BBC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PearTreePharmaceuticalsIncMember" xlink:label="loc_dare_PearTreePharmaceuticalsIncMember_1D3D3D65D5F4FE52C972988EB374605F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4A340493B2421FB3C53B988EB3743BBC" xlink:to="loc_dare_PearTreePharmaceuticalsIncMember_1D3D3D65D5F4FE52C972988EB374605F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerLineItems" xlink:label="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_ScheduleOfBusinessCombinationReverseMergerTable_645B69D56C766E61C186988EB36D30AC" xlink:to="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_StockPurchaseAndOtherTransactionsCompletionDate" xlink:label="loc_dare_StockPurchaseAndOtherTransactionsCompletionDate_2FD650BC80B451FB1BBB988EB3758703" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_StockPurchaseAndOtherTransactionsCompletionDate_2FD650BC80B451FB1BBB988EB3758703" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_StockPurchaseAgreementDate" xlink:label="loc_dare_StockPurchaseAgreementDate_0D96A20D08E7DD8BF98F988EB37536D3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_StockPurchaseAgreementDate_0D96A20D08E7DD8BF98F988EB37536D3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_70CDA993FC186A61A1EA988EB3750E2A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_70CDA993FC186A61A1EA988EB3750E2A" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions" xlink:label="loc_dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions_57BF742C12EA903748F0988EB375FFAD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions_57BF742C12EA903748F0988EB375FFAD" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_StockOptionModificationApprovalDate" xlink:label="loc_dare_StockOptionModificationApprovalDate_15925D8B9D60D12E94D1988EB3755BAF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_StockOptionModificationApprovalDate_15925D8B9D60D12E94D1988EB3755BAF" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerStockPurchaseTransactionCost" xlink:label="loc_dare_BusinessCombinationReverseMergerStockPurchaseTransactionCost_1990FD2D97686FFFE94F988EB376C641" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_BusinessCombinationReverseMergerStockPurchaseTransactionCost_1990FD2D97686FFFE94F988EB376C641" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerConsiderationTransferred" xlink:label="loc_dare_BusinessCombinationReverseMergerConsiderationTransferred_D2C07F46B05223B7A920988EB3765D31" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_BusinessCombinationReverseMergerConsiderationTransferred_D2C07F46B05223B7A920988EB3765D31" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationPurchasePriceAdjustmentIncreaseInCurrentLiabilities" xlink:label="loc_dare_BusinessCombinationPurchasePriceAdjustmentIncreaseInCurrentLiabilities_1EC8DB7C04ADF087A120988EB3769395" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_BusinessCombinationPurchasePriceAdjustmentIncreaseInCurrentLiabilities_1EC8DB7C04ADF087A120988EB3769395" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationPurchasePriceAdjustmentIncreaseInCurrentAssets" xlink:label="loc_dare_BusinessCombinationPurchasePriceAdjustmentIncreaseInCurrentAssets_20457E3812FA6A570674988EB37678E7" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_BusinessCombinationPurchasePriceAdjustmentIncreaseInCurrentAssets_20457E3812FA6A570674988EB37678E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_760A67C44A9570E3D679988EB3767213" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_760A67C44A9570E3D679988EB3767213" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_2E1B6C00ADD6CABC6FB2988EB376580F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_2E1B6C00ADD6CABC6FB2988EB376580F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_B1CC37A32599488000DE988EB37788C7" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_B1CC37A32599488000DE988EB37788C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_2BC79DED165162B89EF9988EB37795E8" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_Goodwill_2BC79DED165162B89EF9988EB37795E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_14BB5311EFB2A013ED8A988EB377F9F3" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_14BB5311EFB2A013ED8A988EB377F9F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_51F2AE5BFE3C002655A4988EB3774FEB" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_51F2AE5BFE3C002655A4988EB3774FEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_925E927365AE22BDE1E3988EB37732CC" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_925E927365AE22BDE1E3988EB37732CC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PotentialCashPaymentsToAcquireBusiness" xlink:label="loc_dare_PotentialCashPaymentsToAcquireBusiness_15E4CB794ABF01F66937988EB377F1CE" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerLineItems_53441F71767888759CB1988EB374A799" xlink:to="loc_dare_PotentialCashPaymentsToAcquireBusiness_15E4CB794ABF01F66937988EB377F1CE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AcquisitionsScheduleOfPurchasePriceConsiderationAllocationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_832B0E92B39F47C125E84CA0CA912384" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_dare_BusinessCombinationReverseMergerConsiderationTransferredEquityInterestsIssuedAndIssuable_F6C1A44F0E95FCB3CE534CA0CA93F12A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_832B0E92B39F47C125E84CA0CA912384" xlink:to="loc_dare_BusinessCombinationReverseMergerConsiderationTransferredEquityInterestsIssuedAndIssuable_F6C1A44F0E95FCB3CE534CA0CA93F12A" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions" xlink:label="loc_dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions_7A713BB679738C5EDAD04CA0CA9351C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_832B0E92B39F47C125E84CA0CA912384" xlink:to="loc_dare_BusinessCombinationReverseMergerUnamortizedFairValueOfStockOptions_7A713BB679738C5EDAD04CA0CA9351C5" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerConsiderationTransferred" xlink:label="loc_dare_BusinessCombinationReverseMergerConsiderationTransferred_A249E51068BCE37F7AC44CA0CA931488" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_832B0E92B39F47C125E84CA0CA912384" xlink:to="loc_dare_BusinessCombinationReverseMergerConsiderationTransferred_A249E51068BCE37F7AC44CA0CA931488" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_6D906CE24AFEFB5E1A494CA0CA939C08" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_832B0E92B39F47C125E84CA0CA912384" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_6D906CE24AFEFB5E1A494CA0CA939C08" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3E2EF568CBFD42B5C9FE4CA0CA93B22F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_6D906CE24AFEFB5E1A494CA0CA939C08" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3E2EF568CBFD42B5C9FE4CA0CA93B22F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherCurrentAssets" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherCurrentAssets_34BE1B890D38B6DDDC334CA0CA9366C4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_6D906CE24AFEFB5E1A494CA0CA939C08" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherCurrentAssets_34BE1B890D38B6DDDC334CA0CA9366C4" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1786FD489517C7F6BB314CA0CA933E75" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_6D906CE24AFEFB5E1A494CA0CA939C08" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1786FD489517C7F6BB314CA0CA933E75" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_A54107390898A43D61DB4CA0CA932042" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_6D906CE24AFEFB5E1A494CA0CA939C08" xlink:to="loc_dare_BusinessCombinationReverseMergerRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_A54107390898A43D61DB4CA0CA932042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_9C782FC5C8FB0DF644784CA0CA93294C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_832B0E92B39F47C125E84CA0CA912384" xlink:to="loc_us-gaap_Goodwill_9C782FC5C8FB0DF644784CA0CA93294C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_33696D0C965B5DAD8A7D80CF74F39006" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ScheduleOfBusinessCombinationReverseMergerTextBlock" xlink:label="loc_dare_ScheduleOfBusinessCombinationReverseMergerTextBlock_85ABBEED9BF65F8C88034691ABCAC79E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_33696D0C965B5DAD8A7D80CF74F39006" xlink:to="loc_dare_ScheduleOfBusinessCombinationReverseMergerTextBlock_85ABBEED9BF65F8C88034691ABCAC79E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9011CCD548C94268B8655B0CFC3E571D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_EC017C87C964FC242A865B0CFC3FE23B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9011CCD548C94268B8655B0CFC3E571D" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_EC017C87C964FC242A865B0CFC3FE23B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_07D484341FC79EBC7FC89A56000418AB" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_CommitmentsAndContingenciesTable" xlink:label="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_07D484341FC79EBC7FC89A56000418AB" xlink:to="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_5226954CA22B824B3BF29A5600047536" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_5226954CA22B824B3BF29A5600047536" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProjectMember" xlink:label="loc_us-gaap_ProjectMember_1204BFFFC315296D30709A5600044412" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_5226954CA22B824B3BF29A5600047536" xlink:to="loc_us-gaap_ProjectMember_1204BFFFC315296D30709A5600044412" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember" xlink:label="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_98769D6901002B06AA839A560004BF7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_1204BFFFC315296D30709A5600044412" xlink:to="loc_dare_UponAchievementOfSpecifiedDevelopmentAndRegulatoryMilestonesMember_98769D6901002B06AA839A560004BF7F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponReachingCertainWorldwideNetSalesMilestonesMember" xlink:label="loc_dare_UponReachingCertainWorldwideNetSalesMilestonesMember_50C351C39922DEDE006E9A5600043689" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_1204BFFFC315296D30709A5600044412" xlink:to="loc_dare_UponReachingCertainWorldwideNetSalesMilestonesMember_50C351C39922DEDE006E9A5600043689" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponAchievementOfSpecifiedCommercializationMilestonesMember" xlink:label="loc_dare_UponAchievementOfSpecifiedCommercializationMilestonesMember_39B96A41607AD303190C9A7E3F93C74B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_1204BFFFC315296D30709A5600044412" xlink:to="loc_dare_UponAchievementOfSpecifiedCommercializationMilestonesMember_39B96A41607AD303190C9A7E3F93C74B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_C411893F38F50A8F70E79A5600042D01" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_C411893F38F50A8F70E79A5600042D01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_C411893F38F50A8F70E79A5600042D01" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponAchievingCertainCommercialMilestonesMember" xlink:label="loc_dare_UponAchievingCertainCommercialMilestonesMember_758ED85E852D6BDD8A1A9A560004A56D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:to="loc_dare_UponAchievingCertainCommercialMilestonesMember_758ED85E852D6BDD8A1A9A560004A56D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponSigningOfDevelopmentAndOptionAgreementMember" xlink:label="loc_dare_UponSigningOfDevelopmentAndOptionAgreementMember_6BFE06515276F44C86869A5600142816" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:to="loc_dare_UponSigningOfDevelopmentAndOptionAgreementMember_6BFE06515276F44C86869A5600142816" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponCompletionOfFiftyPercentDevelopmentNotLaterThanSixMonthsMember" xlink:label="loc_dare_UponCompletionOfFiftyPercentDevelopmentNotLaterThanSixMonthsMember_A7F214FB1B5EA8C8B8DF9A5600144764" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:to="loc_dare_UponCompletionOfFiftyPercentDevelopmentNotLaterThanSixMonthsMember_A7F214FB1B5EA8C8B8DF9A5600144764" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponAchievingCertainDevelopmentMilestonesMember" xlink:label="loc_dare_UponAchievingCertainDevelopmentMilestonesMember_6EF4E3B29F5F1C6E17339A560014E299" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:to="loc_dare_UponAchievingCertainDevelopmentMilestonesMember_6EF4E3B29F5F1C6E17339A560014E299" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember" xlink:label="loc_dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember_47601C1304B5433057CD9A56001444BE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6A27705050929DD3B4929A5600040F89" xlink:to="loc_dare_UponAchievingCertainClinicalAndRegulatoryDevelopmentMilestonesMember_47601C1304B5433057CD9A56001444BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_A5F48F4F6A83318C78569A560014E751" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_A5F48F4F6A83318C78569A560014E751" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3280554863447EC9E2B29A560014956C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_A5F48F4F6A83318C78569A560014E751" xlink:to="loc_us-gaap_RelatedPartyDomain_3280554863447EC9E2B29A560014956C" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember" xlink:label="loc_dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember_2BE18553FE162BBA3E429A560014A2AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3280554863447EC9E2B29A560014956C" xlink:to="loc_dare_StrategicScienceAndTechnologiesDLimitedLiabilityCompanyAndStrategicScienceTechnologiesLimitedLiabilityCompanyMember_2BE18553FE162BBA3E429A560014A2AD" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_OrbisMember" xlink:label="loc_dare_OrbisMember_CD8CA70051BF6338844D9A560014F300" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3280554863447EC9E2B29A560014956C" xlink:to="loc_dare_OrbisMember_CD8CA70051BF6338844D9A560014F300" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_MilanaPharmMember" xlink:label="loc_dare_MilanaPharmMember_62745BECE235C3F3A8979A5600145009" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3280554863447EC9E2B29A560014956C" xlink:to="loc_dare_MilanaPharmMember_62745BECE235C3F3A8979A5600145009" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_HammockPharmaceuticalsInc.Member" xlink:label="loc_dare_HammockPharmaceuticalsInc.Member_0DD342201994E71532B99A5600143869" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3280554863447EC9E2B29A560014956C" xlink:to="loc_dare_HammockPharmaceuticalsInc.Member_0DD342201994E71532B99A5600143869" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_D2219D9BB0711A3D41E39A560014E021" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_us-gaap_TypeOfArrangementAxis_D2219D9BB0711A3D41E39A560014E021" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_D2219D9BB0711A3D41E39A560014E021" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_1D3E842F4EFE0E3BB98B9A5600143699" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:to="loc_us-gaap_LicensingAgreementsMember_1D3E842F4EFE0E3BB98B9A5600143699" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_AssignmentAgreementMember" xlink:label="loc_dare_AssignmentAgreementMember_96857C39E55F481E65BD9A5600147302" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:to="loc_dare_AssignmentAgreementMember_96857C39E55F481E65BD9A5600147302" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAndCollaborationAgreementMember" xlink:label="loc_dare_LicenseAndCollaborationAgreementMember_B3E62F718A04FE6901589A56001426A0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:to="loc_dare_LicenseAndCollaborationAgreementMember_B3E62F718A04FE6901589A56001426A0" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_DevelopmentAndOptionAgreementMember" xlink:label="loc_dare_DevelopmentAndOptionAgreementMember_5AA91B1D560B61EBD8E19A5600143961" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:to="loc_dare_DevelopmentAndOptionAgreementMember_5AA91B1D560B61EBD8E19A5600143961" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_JuniperPharmaceuticalsInc.Member" xlink:label="loc_dare_JuniperPharmaceuticalsInc.Member_72D9E8CEA61D402E65569A560014A18B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:to="loc_dare_JuniperPharmaceuticalsInc.Member_72D9E8CEA61D402E65569A560014A18B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_JuniperPharmaceuticalsMember" xlink:label="loc_dare_JuniperPharmaceuticalsMember_50114727EDF37823F9FA9A560014A640" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_19B1C2BB56A8648E26369A560014E530" xlink:to="loc_dare_JuniperPharmaceuticalsMember_50114727EDF37823F9FA9A560014A640" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_A0158D96A503FC2CC3BE9A56001481A5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_A0158D96A503FC2CC3BE9A56001481A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_EA4F5017546F337CFB1D9A560014C7D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_A0158D96A503FC2CC3BE9A56001481A5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_EA4F5017546F337CFB1D9A560014C7D2" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ADVATecAgreementMember" xlink:label="loc_dare_ADVATecAgreementMember_969471B2814694C360949A560014892D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_EA4F5017546F337CFB1D9A560014C7D2" xlink:to="loc_dare_ADVATecAgreementMember_969471B2814694C360949A560014892D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ClinicalAndRegulatoryMilestonesMember" xlink:label="loc_dare_ClinicalAndRegulatoryMilestonesMember_E86D6B5DF4A6F3B1ADF99A560014C1B9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_EA4F5017546F337CFB1D9A560014C7D2" xlink:to="loc_dare_ClinicalAndRegulatoryMilestonesMember_E86D6B5DF4A6F3B1ADF99A560014C1B9" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_SalesMilestonesMember" xlink:label="loc_dare_SalesMilestonesMember_B041AF0AC6FB606A58559A560014BF2E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_EA4F5017546F337CFB1D9A560014C7D2" xlink:to="loc_dare_SalesMilestonesMember_B041AF0AC6FB606A58559A560014BF2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_354CDF255C05767CA7DF9A560014205B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_srt_RangeAxis_354CDF255C05767CA7DF9A560014205B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_00B86CCB992413FA89259A560014701A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_354CDF255C05767CA7DF9A560014205B" xlink:to="loc_srt_RangeMember_00B86CCB992413FA89259A560014701A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_A2D17817970D187DE9509A560014D4C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_00B86CCB992413FA89259A560014701A" xlink:to="loc_srt_MinimumMember_A2D17817970D187DE9509A560014D4C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_093995F495C3B27368769A560014D735" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_00B86CCB992413FA89259A560014701A" xlink:to="loc_srt_MaximumMember_093995F495C3B27368769A560014D735" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_59563A40B783DB2D84E29A560014A873" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_srt_ProductOrServiceAxis_59563A40B783DB2D84E29A560014A873" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_DA798FDC0287133632209A5600144AED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_59563A40B783DB2D84E29A560014A873" xlink:to="loc_srt_ProductsAndServicesDomain_DA798FDC0287133632209A5600144AED" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_OvapreneMember" xlink:label="loc_dare_OvapreneMember_C20E64FE5DE4896696749A560014E0FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_DA798FDC0287133632209A5600144AED" xlink:to="loc_dare_OvapreneMember_C20E64FE5DE4896696749A560014E0FC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_CommitmentsAndContingenciesLineItems" xlink:label="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesTable_38764C78A6D822C742859A560004D15D" xlink:to="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NumberOfPatentsIssued" xlink:label="loc_dare_NumberOfPatentsIssued_E80D88B0800F8FB720519A5600149998" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_NumberOfPatentsIssued_E80D88B0800F8FB720519A5600149998" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NumberOfPendingPatents" xlink:label="loc_dare_NumberOfPendingPatents_1BC6D5630F25BABAEFBC9A560024F8DC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_NumberOfPendingPatents_1BC6D5630F25BABAEFBC9A560024F8DC" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NumberOfPatentsGranted" xlink:label="loc_dare_NumberOfPatentsGranted_45780CDADC370C3630C69A560024A0FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_NumberOfPatentsGranted_45780CDADC370C3630C69A560024A0FB" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NumberOfPatentApplications" xlink:label="loc_dare_NumberOfPatentApplications_928D3B145E48D14FAF449A5600244E6C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_NumberOfPatentApplications_928D3B145E48D14FAF449A5600244E6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_F535BA93A17C5B8828289A560024ABB9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_us-gaap_ContractualObligation_F535BA93A17C5B8828289A560024ABB9" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_AgreementTerminationPeriodOnFailingToCommercializeInCertainDesignatedCountries" xlink:label="loc_dare_AgreementTerminationPeriodOnFailingToCommercializeInCertainDesignatedCountries_52FAD2A4EB67740EB0699A5600246699" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_AgreementTerminationPeriodOnFailingToCommercializeInCertainDesignatedCountries_52FAD2A4EB67740EB0699A5600246699" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NumberOfDesignatedCountries" xlink:label="loc_dare_NumberOfDesignatedCountries_BB66673F56F2430B455D9A5600240127" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_NumberOfDesignatedCountries_BB66673F56F2430B455D9A5600240127" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PercentageOfRoyaltyRate" xlink:label="loc_dare_PercentageOfRoyaltyRate_6C247173C8CDB6CBDF8A9A560024E842" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_PercentageOfRoyaltyRate_6C247173C8CDB6CBDF8A9A560024E842" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure" xlink:label="loc_dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure_40A4F7505810715F6AEA9A56002444E2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementTerminationPeriodDueToPerformanceFailure_40A4F7505810715F6AEA9A56002444E2" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_AgreementTerminationOnFailingToEnrollPatientWithinMonthsOfProductionAndRelease" xlink:label="loc_dare_AgreementTerminationOnFailingToEnrollPatientWithinMonthsOfProductionAndRelease_C9A2BF985131F6143FFD9A560024E498" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_AgreementTerminationOnFailingToEnrollPatientWithinMonthsOfProductionAndRelease_C9A2BF985131F6143FFD9A560024E498" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement" xlink:label="loc_dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement_00DFD9685A4BF88AB74D9A5600245D3A" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_PercentageOfRightsToInventionsByEmployeesUnderLicenseAgreement_00DFD9685A4BF88AB74D9A5600245D3A" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_MilestonePaymentsContingentAmount" xlink:label="loc_dare_MilestonePaymentsContingentAmount_B78283700539874CDE8F9A56002440B7" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_MilestonePaymentsContingentAmount_B78283700539874CDE8F9A56002440B7" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_SecuredInvestmentRequiredForLicenseAgreement" xlink:label="loc_dare_SecuredInvestmentRequiredForLicenseAgreement_872582390F9D53AF2AAE9A560024DD41" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_SecuredInvestmentRequiredForLicenseAgreement_872582390F9D53AF2AAE9A560024DD41" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementExpirationPeriod" xlink:label="loc_dare_LicenseAgreementExpirationPeriod_A0108DD623BAE0B6903F9A560024047E" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementExpirationPeriod_A0108DD623BAE0B6903F9A560024047E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementTerminationPeriodPriorToReceiptOfApproval" xlink:label="loc_dare_LicenseAgreementTerminationPeriodPriorToReceiptOfApproval_FBB837D21481090AF7219A560024FFF8" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementTerminationPeriodPriorToReceiptOfApproval_FBB837D21481090AF7219A560024FFF8" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementTerminationPeriodAfterReceiptOfApproval" xlink:label="loc_dare_LicenseAgreementTerminationPeriodAfterReceiptOfApproval_76CCC3476D3257EABB9C9A56002489B5" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementTerminationPeriodAfterReceiptOfApproval_76CCC3476D3257EABB9C9A56002489B5" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementTerminationPeriodForApplicableLicenseProductsOfApplicableCountries" xlink:label="loc_dare_LicenseAgreementTerminationPeriodForApplicableLicenseProductsOfApplicableCountries_F124726C3421E867D1CD9A5600240049" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementTerminationPeriodForApplicableLicenseProductsOfApplicableCountries_F124726C3421E867D1CD9A5600240049" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NoticePeriodForTerminationOfAgreementForBothParties" xlink:label="loc_dare_NoticePeriodForTerminationOfAgreementForBothParties_CF6435B3AEFC7CBAB3F79A56002444A9" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_NoticePeriodForTerminationOfAgreementForBothParties_CF6435B3AEFC7CBAB3F79A56002444A9" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ResearchAndDevelopmentMilestonePayment" xlink:label="loc_dare_ResearchAndDevelopmentMilestonePayment_EC3B4824F10C9177D2209A560024FEBE" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_ResearchAndDevelopmentMilestonePayment_EC3B4824F10C9177D2209A560024FEBE" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_CommencementPeriodForStageTwoUponAchievementOfStageOne" xlink:label="loc_dare_CommencementPeriodForStageTwoUponAchievementOfStageOne_5810BD177D60B22254289A5600246007" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_CommencementPeriodForStageTwoUponAchievementOfStageOne_5810BD177D60B22254289A5600246007" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UpfrontLicenseFeePaid" xlink:label="loc_dare_UpfrontLicenseFeePaid_5D7D2EC543FF757133159A5600242C6F" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_UpfrontLicenseFeePaid_5D7D2EC543FF757133159A5600242C6F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne" xlink:label="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne_56BD0638CD219DCA6E4C9A5600240E89" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsInYearOne_56BD0638CD219DCA6E4C9A5600240E89" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter" xlink:label="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter_3D2EBD3A7E3D9B6AAA1A9A5600245A33" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_PotentialAnnualLicenseMaintenanceFeePaymentsThereafter_3D2EBD3A7E3D9B6AAA1A9A5600245A33" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_MaximumPotentialMilestonePayments" xlink:label="loc_dare_MaximumPotentialMilestonePayments_1E20C25B4B9697F644BD9A5600242F55" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_MaximumPotentialMilestonePayments_1E20C25B4B9697F644BD9A5600242F55" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementPeriodOfContinuationFromDateOfFirstCommercialSaleOfProductOrProcess" xlink:label="loc_dare_LicenseAgreementPeriodOfContinuationFromDateOfFirstCommercialSaleOfProductOrProcess_F6B481148AECD100D2579A560024091F" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementPeriodOfContinuationFromDateOfFirstCommercialSaleOfProductOrProcess_F6B481148AECD100D2579A560024091F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfPaymentObligation" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfPaymentObligation_E8FDC8D4D591972F80549A56002430AE" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfPaymentObligation_E8FDC8D4D591972F80549A56002430AE" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PeriodOfDismissalOfBankruptcyPetition" xlink:label="loc_dare_PeriodOfDismissalOfBankruptcyPetition_9A66142D7D6466E0B3849A5600334DD1" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_PeriodOfDismissalOfBankruptcyPetition_9A66142D7D6466E0B3849A5600334DD1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfOtherObligation" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfOtherObligation_3172676B13C81A8A8C329A560033F776" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTerminationForBreachOfOtherObligation_3172676B13C81A8A8C329A560033F776" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseAgreementNoticePeriodOfTermination" xlink:label="loc_dare_LicenseAgreementNoticePeriodOfTermination_9DD65469CF7431C21BEE9A5600339C9B" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseAgreementNoticePeriodOfTermination_9DD65469CF7431C21BEE9A5600339C9B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseFee" xlink:label="loc_dare_LicenseFee_EC70CA24DF2CC78006AD9A5600331328" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseFee_EC70CA24DF2CC78006AD9A5600331328" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseFeeToBePaidUponContingency" xlink:label="loc_dare_LicenseFeeToBePaidUponContingency_EC3867FD1715A408E3DB9A560033532E" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_LicenseFeeToBePaidUponContingency_EC3867FD1715A408E3DB9A560033532E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ProceedsRaisedFromEquityFinancing" xlink:label="loc_dare_ProceedsRaisedFromEquityFinancing_E39FDEFAFEF3860A55E39A5600336B8F" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_CommitmentsAndContingenciesLineItems_0083987B86416E941F839A56001435E9" xlink:to="loc_dare_ProceedsRaisedFromEquityFinancing_E39FDEFAFEF3860A55E39A5600336B8F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_AB21A797C075135B8E6AB2D49A813330" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_123DE0AC56DE9BC79B4AB2D49A8256C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_AB21A797C075135B8E6AB2D49A813330" xlink:to="loc_us-gaap_AssetsAbstract_123DE0AC56DE9BC79B4AB2D49A8256C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3FEA17BE08F56C6526B6B2D49A8282EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_123DE0AC56DE9BC79B4AB2D49A8256C9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3FEA17BE08F56C6526B6B2D49A8282EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ABE0931011721201B5FAB2D49A8214D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3FEA17BE08F56C6526B6B2D49A8282EC" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ABE0931011721201B5FAB2D49A8214D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_D6FCA347B3D4648DCB50B2D49A83C087" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3FEA17BE08F56C6526B6B2D49A8282EC" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_D6FCA347B3D4648DCB50B2D49A83C087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_5DC654A67EB2185D6BEAB2D49A83FFDC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3FEA17BE08F56C6526B6B2D49A8282EC" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_5DC654A67EB2185D6BEAB2D49A83FFDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_4B3A9F71C7A6EFF08FC8B2D49A83F169" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3FEA17BE08F56C6526B6B2D49A8282EC" xlink:to="loc_us-gaap_AssetsCurrent_4B3A9F71C7A6EFF08FC8B2D49A83F169" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_E28002A7A0DB89AFF8DCB2D49A837B8C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_123DE0AC56DE9BC79B4AB2D49A8256C9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_E28002A7A0DB89AFF8DCB2D49A837B8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_A4B841C11C10D20EFDC3B2D49A835AF8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_123DE0AC56DE9BC79B4AB2D49A8256C9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_A4B841C11C10D20EFDC3B2D49A835AF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_C3B9FC7C5903C1A529E7B2D49A848A5E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_123DE0AC56DE9BC79B4AB2D49A8256C9" xlink:to="loc_us-gaap_Assets_C3B9FC7C5903C1A529E7B2D49A848A5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_AB21A797C075135B8E6AB2D49A813330" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_E2B2F4CE9A829CE90488B2D49A84A2D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_E2B2F4CE9A829CE90488B2D49A84A2D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_BE8607A134CF73B9CCE6B2D49A84B637" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_E2B2F4CE9A829CE90488B2D49A84A2D6" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_BE8607A134CF73B9CCE6B2D49A84B637" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_38EDE4F41CCB20C58EBAB2D49A844E7B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_E2B2F4CE9A829CE90488B2D49A84A2D6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_38EDE4F41CCB20C58EBAB2D49A844E7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_FB95DBE26ACB747CD115B2D49A859870" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_E2B2F4CE9A829CE90488B2D49A84A2D6" xlink:to="loc_us-gaap_LiabilitiesCurrent_FB95DBE26ACB747CD115B2D49A859870" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_EB6EE3B2DFE344447686B2D49A8527E0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_EB6EE3B2DFE344447686B2D49A8527E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_2AAC2C2247D518B37963B2D49A851B7F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:to="loc_us-gaap_Liabilities_2AAC2C2247D518B37963B2D49A851B7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_121DEFF3EAAD3E3CE959B2D49A859685" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:to="loc_us-gaap_CommitmentsAndContingencies_121DEFF3EAAD3E3CE959B2D49A859685" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:to="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_68F21DF223626E4054B1B2D49A856E86" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:to="loc_us-gaap_PreferredStockValue_68F21DF223626E4054B1B2D49A856E86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_4E2175BFC2B3D4348DFBB2D49A86A1E0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:to="loc_us-gaap_CommonStockValue_4E2175BFC2B3D4348DFBB2D49A86A1E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_258ECFF68924BF54A433B2D49A86F553" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_258ECFF68924BF54A433B2D49A86F553" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_F4562C692B4CA60A8EB5B2D49A862726" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_F4562C692B4CA60A8EB5B2D49A862726" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0E784BF2B76ABD43E43FB2D49A86E6C9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0E784BF2B76ABD43E43FB2D49A86E6C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_69EA62674167734AAC32B2D49A873274" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_D5C23961379911476F6FB2D49A85E8D8" xlink:to="loc_us-gaap_StockholdersEquity_69EA62674167734AAC32B2D49A873274" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0AAE7F70EC2B0CE25892B2D49A87017F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_806763A8247A490451C2B2D49A84965F" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0AAE7F70EC2B0CE25892B2D49A87017F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_DE883CE1F5ACA9FB28AB4AFD87A90115" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_DE883CE1F5ACA9FB28AB4AFD87A90115" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_42774BA14B3F9AE466784AFD87A944E4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_42774BA14B3F9AE466784AFD87A944E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_445473AEC3E5D80A9CE84AFD87A9C16C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_PreferredStockSharesIssued_445473AEC3E5D80A9CE84AFD87A9C16C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_E0B9F9ACB71325C4A9524AFD87A9DC4E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_E0B9F9ACB71325C4A9524AFD87A9DC4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4C203616CB1F8C6B2BA24AFD87AA0329" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4C203616CB1F8C6B2BA24AFD87AA0329" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4D5F6671C099F82A84E94AFD87AA93B5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4D5F6671C099F82A84E94AFD87AA93B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3BC28C6E72004E449D8A4AFD87AAA191" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_CommonStockSharesIssued_3BC28C6E72004E449D8A4AFD87AAA191" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ACFFBBD10E1A526332C54AFD87AA9B8F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47947645EBAF5BA368994AFD87A9CB15" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ACFFBBD10E1A526332C54AFD87AA9B8F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_D317E1C869256790D1ACB18BDA91E9FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_D317E1C869256790D1ACB18BDA91E9FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1AAB14F900E12EA90688B18BDA9157DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_D317E1C869256790D1ACB18BDA91E9FE" xlink:to="loc_us-gaap_ProfitLoss_1AAB14F900E12EA90688B18BDA9157DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_D317E1C869256790D1ACB18BDA91E9FE" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_335F3165B19CE4F74A3AB18BDA918747" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:to="loc_us-gaap_Depreciation_335F3165B19CE4F74A3AB18BDA918747" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_CBB2E103E47833399D44B18BDA910971" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:to="loc_us-gaap_ShareBasedCompensation_CBB2E103E47833399D44B18BDA910971" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NonCashLeaseExpense" xlink:label="loc_dare_NonCashLeaseExpense_2FC6C5912A9BD23335E4B18BDA91A93A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:to="loc_dare_NonCashLeaseExpense_2FC6C5912A9BD23335E4B18BDA91A93A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_67738A0E144BA5622195B18BDA9188B5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_67738A0E144BA5622195B18BDA9188B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_C087155E60C4A4F94EADB18BDA91AD6A" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_48C3A7492B921BCCCA78B18BDAA1490B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_48C3A7492B921BCCCA78B18BDAA1490B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_4CAEF4A93DE580FE3F07B18BDAA15F08" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_4CAEF4A93DE580FE3F07B18BDAA15F08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_F70DAC87110DB401A12DB18BDAA19B32" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_F70DAC87110DB401A12DB18BDAA19B32" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges" xlink:label="loc_dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges_33EADA3C1CA2E40BF73EB18BDAA1ACB7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_dare_IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges_33EADA3C1CA2E40BF73EB18BDAA1ACB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_794AA4F2C9C55F0857F1B18BDAA17509" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_794AA4F2C9C55F0857F1B18BDAA17509" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_07700AF16ACE440BD5ECB18BDAA18682" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_07700AF16ACE440BD5ECB18BDAA18682" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0099BD8F996BE4BB30A7B18BDAA1B3D5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7083B0ED7E6C0C375EB3B18BDA918564" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0099BD8F996BE4BB30A7B18BDAA1B3D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_BB43D64CDADC7FC9C139B18BDAA1C220" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_D317E1C869256790D1ACB18BDA91E9FE" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_BB43D64CDADC7FC9C139B18BDAA1C220" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62384E8A2B83F98CA01EB18BDAA107DA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62384E8A2B83F98CA01EB18BDAA107DA" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NetProceedsFromIssuanceOfCommonStockAndWarrants" xlink:label="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_BE061AA701D4AF3EB78AB18BDAA1DE07" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62384E8A2B83F98CA01EB18BDAA107DA" xlink:to="loc_dare_NetProceedsFromIssuanceOfCommonStockAndWarrants_BE061AA701D4AF3EB78AB18BDAA1DE07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_A25A64428EC8E2745F92B18BDAA196FA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_62384E8A2B83F98CA01EB18BDAA107DA" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_A25A64428EC8E2745F92B18BDAA196FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_B278DE1E015E77BC879DB18BDAA147AD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_B278DE1E015E77BC879DB18BDAA147AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0C1CF19A3F309EF9A2F2B18BDAA17F0F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0C1CF19A3F309EF9A2F2B18BDAA17F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_16D36CE99793425C795DB18BDAA1DAC1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_16D36CE99793425C795DB18BDAA1DAC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4A4C0AE7361A6D5905C7B18BDAA1EEE1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4A4C0AE7361A6D5905C7B18BDAA1EEE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7102BCEF3C77AD1F94D7B18BDAA16B19" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6679D68054E11151A2B7B18BDA919557" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7102BCEF3C77AD1F94D7B18BDAA16B19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7F4E3DE34F6FA67EDAADB18BDAA1E4B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7102BCEF3C77AD1F94D7B18BDAA16B19" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7F4E3DE34F6FA67EDAADB18BDAA1E4B7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1171F5538C0EA6545C4798953F314823" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1171F5538C0EA6545C4798953F314823" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_62835F46B665ABD7E86098953F3294FA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_62835F46B665ABD7E86098953F3294FA" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_LicenseFee" xlink:label="loc_dare_LicenseFee_23CCFE06152080F3309698953F32C16B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:to="loc_dare_LicenseFee_23CCFE06152080F3309698953F32C16B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_E13152499468E59FF9B698953F3267F5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_E13152499468E59FF9B698953F3267F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_4C0BD30350432AB1AFAC98953F32B9D6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3E2032EDAA9D158D248598953F312E1D" xlink:to="loc_us-gaap_OperatingExpenses_4C0BD30350432AB1AFAC98953F32B9D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_E0E7F18781E37DEBB68498953F32985A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_OperatingIncomeLoss_E0E7F18781E37DEBB68498953F32985A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7DD19B35DC5BE04302F798953F33997A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7DD19B35DC5BE04302F798953F33997A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_6C59008EF4D3EF03BB1198953F3388FF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_NetIncomeLoss_6C59008EF4D3EF03BB1198953F3388FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_E3F85B784686DE6A24A598953F33926F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_E3F85B784686DE6A24A598953F33926F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_56566AB84F7C1EF7E9FF98953F332116" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_56566AB84F7C1EF7E9FF98953F332116" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_46D95E701B8A457EB3CD98953F332419" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_46D95E701B8A457EB3CD98953F332419" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_D3B9167ECF2C28DA403E98953F3307C4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9B95EB975FB076A9931D98953F31ED26" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_D3B9167ECF2C28DA403E98953F3307C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6765405C1D1C312512F498953F3463BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_D3B9167ECF2C28DA403E98953F3307C4" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_6765405C1D1C312512F498953F3463BF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7A4924DC0BD237E80F0C9A56025F80CF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_0D8407D9AF6A49CC828C9A56025FDE1D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7A4924DC0BD237E80F0C9A56025F80CF" xlink:to="loc_us-gaap_StatementTable_0D8407D9AF6A49CC828C9A56025FDE1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_C9B92ABFCFCA94D0DC759A56025FC687" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0D8407D9AF6A49CC828C9A56025FDE1D" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_C9B92ABFCFCA94D0DC759A56025FC687" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_0A1E880EE9B0B38CC5939A56025F55CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_C9B92ABFCFCA94D0DC759A56025FC687" xlink:to="loc_us-gaap_EquityComponentDomain_0A1E880EE9B0B38CC5939A56025F55CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_5655E775302341B229589A56025FC4E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0A1E880EE9B0B38CC5939A56025F55CD" xlink:to="loc_us-gaap_CommonStockMember_5655E775302341B229589A56025FC4E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_A4269AD8803217CE0CD09A56025FAA1E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0A1E880EE9B0B38CC5939A56025F55CD" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_A4269AD8803217CE0CD09A56025FAA1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3C1E4AFF00DDAC8931BE9A56025F39ED" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0A1E880EE9B0B38CC5939A56025F55CD" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3C1E4AFF00DDAC8931BE9A56025F39ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_ED1DB1061AF786E377429A56025FC1F2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0A1E880EE9B0B38CC5939A56025F55CD" xlink:to="loc_us-gaap_RetainedEarningsMember_ED1DB1061AF786E377429A56025FC1F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_9A2DA989A8F8700921189A56025F903C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0D8407D9AF6A49CC828C9A56025FDE1D" xlink:to="loc_us-gaap_StatementLineItems_9A2DA989A8F8700921189A56025F903C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9A2DA989A8F8700921189A56025F903C" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_B4A669E84ED4CD87D93C9A56025FB2C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_SharesOutstanding_B4A669E84ED4CD87D93C9A56025FB2C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7F685565E0403878AC429A56025F0EF6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_StockholdersEquity_7F685565E0403878AC429A56025F0EF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5A6FAB27765356E493E89A56025F1DDB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5A6FAB27765356E493E89A56025F1DDB" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares" xlink:label="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares_A57FC78530EFE2FD37759A5A97200D70" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssuedShares_A57FC78530EFE2FD37759A5A97200D70" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssued" xlink:label="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssued_2F693C9DFD1A02DFA3339A5A0441C9EC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_dare_AdjustmentsToAdditionalPaidInCapitalCommonStockAndWarrantsIssued_2F693C9DFD1A02DFA3339A5A0441C9EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2F6D6B4B0041ECC832599A5BCDACC151" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2F6D6B4B0041ECC832599A5BCDACC151" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_F9F3FF8C2B45048CCB999A5B3F34E3D9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_F9F3FF8C2B45048CCB999A5B3F34E3D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_09D5EBDF1E1FFB0810DE9A56025F8EA4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_NetIncomeLoss_09D5EBDF1E1FFB0810DE9A56025F8EA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_17A93AB3F7B86CAE5C9E9A56025FC352" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_17A93AB3F7B86CAE5C9E9A56025FC352" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_D617E4A4CAE2BF62AC519A56025F8245" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_SharesOutstanding_D617E4A4CAE2BF62AC519A56025F8245" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6A4D455ED71837E37A899A56025FDE22" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_80636016A33DCF6BF88A9A56025FAA25" xlink:to="loc_us-gaap_StockholdersEquity_6A4D455ED71837E37A899A56025FDE22" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="dare-20190331.xsd#dare_DocumentAndEntityInformationAbstract" xlink:label="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_07305CB1EC745D48ADDDEB7EEAA5D182" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_DocumentType_07305CB1EC745D48ADDDEB7EEAA5D182" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_280A3A115DAB58579CBBA2B59E09495A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_AmendmentFlag_280A3A115DAB58579CBBA2B59E09495A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_E4865217EE045911A68CF25D5BA6E7AB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_DocumentPeriodEndDate_E4865217EE045911A68CF25D5BA6E7AB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_991B8F8AC33B53619ECF0784A4608DA1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_DocumentFiscalYearFocus_991B8F8AC33B53619ECF0784A4608DA1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9611D900CD9D514BBF4F557566D7FE1C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9611D900CD9D514BBF4F557566D7FE1C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_1EAC5AFA2A0153569396C7250CAC5142" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_TradingSymbol_1EAC5AFA2A0153569396C7250CAC5142" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_56E1AC418AB65A0E955D80683C4B79C1" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntityRegistrantName_56E1AC418AB65A0E955D80683C4B79C1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_6F706D3E4FD05AF89A678276963FA5AD" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntityCentralIndexKey_6F706D3E4FD05AF89A678276963FA5AD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_01424642A01355F19E1BCCCA27EBCE69" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_CurrentFiscalYearEndDate_01424642A01355F19E1BCCCA27EBCE69" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_E70351BD91285C8D8D6C5E07405D00E0" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntityFilerCategory_E70351BD91285C8D8D6C5E07405D00E0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_EB234353E7F153D6AAFCE94FAACF89B4" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntitySmallBusiness_EB234353E7F153D6AAFCE94FAACF89B4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_E57237172DAF5B3092693081B0FFCD84" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntityEmergingGrowthCompany_E57237172DAF5B3092693081B0FFCD84" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_C84F85B0C1DF5DBD80CCD3B8BE902118" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntityExTransitionPeriod_C84F85B0C1DF5DBD80CCD3B8BE902118" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2BFCE551E548530B91645A4CFA08E7D6" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_DocumentAndEntityInformationAbstract_08DBFF8ED9675105A70B476DBD17D689" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2BFCE551E548530B91645A4CFA08E7D6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GoingConcern" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_EC1AE1EC025EA317C59A5B0CFD7D3670" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_4FB4D6512B5C76E839AE5B0CFD7D0553" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_EC1AE1EC025EA317C59A5B0CFD7D3670" xlink:to="loc_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_4FB4D6512B5C76E839AE5B0CFD7D0553" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GoingConcernAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_BEB3F88D40C7F3B807499A56024F3A99" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_BEB3F88D40C7F3B807499A56024F3A99" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1D0B60342F347D546F3C9A84699279BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1D0B60342F347D546F3C9A84699279BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0970354C206E9163AC609A8469964378" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1D0B60342F347D546F3C9A84699279BB" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0970354C206E9163AC609A8469964378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5D743DF17E387FF9F7049A849F42EB6D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0970354C206E9163AC609A8469964378" xlink:to="loc_us-gaap_SubsequentEventMember_5D743DF17E387FF9F7049A849F42EB6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_6A7A9765388363B2681C9A661723B3F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:to="loc_srt_ProductOrServiceAxis_6A7A9765388363B2681C9A661723B3F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_5451778105F9C033F0509A66172B02B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6A7A9765388363B2681C9A661723B3F9" xlink:to="loc_srt_ProductsAndServicesDomain_5451778105F9C033F0509A66172B02B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_08ABC9667536FF65301A9A661D8A1F59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5451778105F9C033F0509A66172B02B6" xlink:to="loc_us-gaap_GrantMember_08ABC9667536FF65301A9A661D8A1F59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_701EF41A3A73139ED7D89A6615ECC4C7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_701EF41A3A73139ED7D89A6615ECC4C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_72D8568E08EF024BCD5F9A6615F0D669" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_701EF41A3A73139ED7D89A6615ECC4C7" xlink:to="loc_us-gaap_RelatedPartyDomain_72D8568E08EF024BCD5F9A6615F0D669" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NationalInstitutesOfHealthMember" xlink:label="loc_dare_NationalInstitutesOfHealthMember_2A3CE531656E9E3BF9449A66190FDBF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_72D8568E08EF024BCD5F9A6615F0D669" xlink:to="loc_dare_NationalInstitutesOfHealthMember_2A3CE531656E9E3BF9449A66190FDBF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:label="loc_us-gaap_HealthCareTrustFundAxis_0621D943414831A142E39A6615507190" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:to="loc_us-gaap_HealthCareTrustFundAxis_0621D943414831A142E39A6615507190" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:label="loc_us-gaap_HealthCareTrustFundNameDomain_4A026E9C487D6AA2E51C9A661550A251" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundAxis_0621D943414831A142E39A6615507190" xlink:to="loc_us-gaap_HealthCareTrustFundNameDomain_4A026E9C487D6AA2E51C9A661550A251" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember" xlink:label="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_D6372A6B44BC874CA8699A661A89793F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundNameDomain_4A026E9C487D6AA2E51C9A661550A251" xlink:to="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_D6372A6B44BC874CA8699A661A89793F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_B5D20EE39CE78FA0D84F9A6614AC84FE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_B5D20EE39CE78FA0D84F9A6614AC84FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0525603D6DAB9EBAB3859A6614B4D8C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_B5D20EE39CE78FA0D84F9A6614AC84FE" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0525603D6DAB9EBAB3859A6614B4D8C5" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember" xlink:label="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_A2B9627521A2233D65669A6617D1AFBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0525603D6DAB9EBAB3859A6614B4D8C5" xlink:to="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_A2B9627521A2233D65669A6617D1AFBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_C65FCFC94C7020C17E409A661003757E" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1F34DFD916C3E99152E79A56024F6D47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_NetIncomeLoss_1F34DFD916C3E99152E79A56024F6D47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_108E27EC00EFB037FDAD9A56024F194D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_108E27EC00EFB037FDAD9A56024F194D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C843732967C5D5C961E79A56024F68CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C843732967C5D5C961E79A56024F68CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5634AEF9A0FD6D808D4B9A56024FB6C2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5634AEF9A0FD6D808D4B9A56024FB6C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_758204A0F638657C87D49A66138723AC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_758204A0F638657C87D49A66138723AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="loc_us-gaap_GrantsReceivable_F41D57809178DD9499289A6614465A5F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_GrantsReceivable_F41D57809178DD9499289A6614465A5F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ReimbursementOfGrantExpensesReceivable" xlink:label="loc_dare_ReimbursementOfGrantExpensesReceivable_86E85800438703E017EF9A696B36EA73" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_dare_ReimbursementOfGrantExpensesReceivable_86E85800438703E017EF9A696B36EA73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3FDA002F9E23F13D25AB9A56024F7FAB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_C6A9DC7E6F70E08E59849A66100563DE" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3FDA002F9E23F13D25AB9A56024F7FAB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GrantAward" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_F3ADC89DCC63EEF2AC485B0CFBCC2937" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_GrantAwardTextBlock" xlink:label="loc_dare_GrantAwardTextBlock_60E5F4A97C48CE4E8EFC5B0CFBCCFC45" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_F3ADC89DCC63EEF2AC485B0CFBCC2937" xlink:to="loc_dare_GrantAwardTextBlock_60E5F4A97C48CE4E8EFC5B0CFBCCFC45" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/GrantAwardAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaap_ReceivablesAbstract_08C4442328E5C9312FF34B44EE18ADE7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_08C4442328E5C9312FF34B44EE18ADE7" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_23E9D3403EE0E44381D34B44EE205A3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:to="loc_srt_ProductOrServiceAxis_23E9D3403EE0E44381D34B44EE205A3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_3D00AD7B1B42CD93BD694AFD86AB108F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_23E9D3403EE0E44381D34B44EE205A3E" xlink:to="loc_srt_ProductsAndServicesDomain_3D00AD7B1B42CD93BD694AFD86AB108F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_5288ADBCBB79C797AFE54AFD86AB27D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3D00AD7B1B42CD93BD694AFD86AB108F" xlink:to="loc_us-gaap_GrantMember_5288ADBCBB79C797AFE54AFD86AB27D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundAxis" xlink:label="loc_us-gaap_HealthCareTrustFundAxis_70847F1A29F1EA462DFF4B44EE1F1692" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:to="loc_us-gaap_HealthCareTrustFundAxis_70847F1A29F1EA462DFF4B44EE1F1692" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HealthCareTrustFundNameDomain" xlink:label="loc_us-gaap_HealthCareTrustFundNameDomain_97CCA2C445E6505A076B4AFD86AAA61F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundAxis_70847F1A29F1EA462DFF4B44EE1F1692" xlink:to="loc_us-gaap_HealthCareTrustFundNameDomain_97CCA2C445E6505A076B4AFD86AAA61F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember" xlink:label="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_351A433D9E50199380194B426FD37627" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareTrustFundNameDomain_97CCA2C445E6505A076B4AFD86AAA61F" xlink:to="loc_dare_EuniceKennedyShriverNationalInstituteOfChildHealthAndHumanDevelopmentMember_351A433D9E50199380194B426FD37627" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_5C779FA6DDDEA1F81ECC4B44EE1EF86A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_5C779FA6DDDEA1F81ECC4B44EE1EF86A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9D13C508777DE43B11994AFD86AAA62E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_5C779FA6DDDEA1F81ECC4B44EE1EF86A" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9D13C508777DE43B11994AFD86AAA62E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember" xlink:label="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_1D0C11650F066CE3E1A84B4271339683" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9D13C508777DE43B11994AFD86AAA62E" xlink:to="loc_dare_SecondPhaseOfResearchAndAvailabilityOfFundsMember_1D0C11650F066CE3E1A84B4271339683" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_RemainingPortionOfResearchAndAvailabilityOfFundsMember" xlink:label="loc_dare_RemainingPortionOfResearchAndAvailabilityOfFundsMember_5F68CA79C01D1A29D7034B4271EC177A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9D13C508777DE43B11994AFD86AAA62E" xlink:to="loc_dare_RemainingPortionOfResearchAndAvailabilityOfFundsMember_5F68CA79C01D1A29D7034B4271EC177A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1B6FBF7545ABAE4480B94B44EE1D472A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1B6FBF7545ABAE4480B94B44EE1D472A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_0A29BF089F0F05A4009D4AFD86A91A6E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1B6FBF7545ABAE4480B94B44EE1D472A" xlink:to="loc_us-gaap_RelatedPartyDomain_0A29BF089F0F05A4009D4AFD86A91A6E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NationalInstitutesOfHealthMember" xlink:label="loc_dare_NationalInstitutesOfHealthMember_C8092FB0F7B7B382122D4B4270CD8E95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0A29BF089F0F05A4009D4AFD86A91A6E" xlink:to="loc_dare_NationalInstitutesOfHealthMember_C8092FB0F7B7B382122D4B4270CD8E95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4550E0A5A1BED752DA3D4B45614FBAFE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_DBA46B363FAED29C336A4B4561485874" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4550E0A5A1BED752DA3D4B45614FBAFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EAA3DBB7DCB745D015344B44EE21580A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4550E0A5A1BED752DA3D4B45614FBAFE" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_EAA3DBB7DCB745D015344B44EE21580A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="loc_us-gaap_GrantsReceivable_A700E7260F051B02470F4B44EE211D07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4550E0A5A1BED752DA3D4B45614FBAFE" xlink:to="loc_us-gaap_GrantsReceivable_A700E7260F051B02470F4B44EE211D07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_BAB8B5647671C3BAB84D4B44EE21F949" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4550E0A5A1BED752DA3D4B45614FBAFE" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_BAB8B5647671C3BAB84D4B44EE21F949" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ReimbursementOfGrantExpensesReceivable" xlink:label="loc_dare_ReimbursementOfGrantExpensesReceivable_47DA93AB45B5EFA55C6A4B44EE216660" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_4550E0A5A1BED752DA3D4B45614FBAFE" xlink:to="loc_dare_ReimbursementOfGrantExpensesReceivable_47DA93AB45B5EFA55C6A4B44EE216660" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedProperties" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_DB7FB49972D33242032D5B0CFCC91C8A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_F6AA5EB73D169996FD475B0CFCCA9A86" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_DB7FB49972D33242032D5B0CFCC91C8A" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_F6AA5EB73D169996FD475B0CFCCA9A86" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetRentableArea" xlink:label="loc_us-gaap_NetRentableArea_6B5CB2931E6369BCC9EC9A5600814A87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_NetRentableArea_6B5CB2931E6369BCC9EC9A5600814A87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_9C76FD35CFA1573E12829A5600811DAE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_9C76FD35CFA1573E12829A5600811DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_09289270C44F42B3986E9A56008183A0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_09289270C44F42B3986E9A56008183A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_E2C07D8136918033A7EA9A560081C4AB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_E2C07D8136918033A7EA9A560081C4AB" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PercentageOfIncreaseInAnnualBaseRent" xlink:label="loc_dare_PercentageOfIncreaseInAnnualBaseRent_1D6C6620D15B2CCB26A09A56008108DD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_dare_PercentageOfIncreaseInAnnualBaseRent_1D6C6620D15B2CCB26A09A56008108DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_BE13FF9F56D61460AA199A5600815355" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_BE13FF9F56D61460AA199A5600815355" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_30F7E801439B894CE4E99A560081B7EF" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_30F7E801439B894CE4E99A560081B7EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_A10CF1591D363F9CFE689A56008173C9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_A10CF1591D363F9CFE689A56008173C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_3288700E132D697C454A9A5600813EB0" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_OperatingLeaseCost_3288700E132D697C454A9A5600813EB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_2214E395661607D006449A56008183DB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9D6F261031A6C89368DA9A5600819461" xlink:to="loc_us-gaap_OperatingLeasePayments_2214E395661607D006449A56008183DB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesLeasedPropertiesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1E9A5BEA833D05630757A2CBCDE0C7A2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1E9A5BEA833D05630757A2CBCDE0C7A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_98FD05DB67D25A812E16A2CAE89DDC2E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_98FD05DB67D25A812E16A2CAE89DDC2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D077CEB697C13FF63BABA2CAE89EECA1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_D077CEB697C13FF63BABA2CAE89EECA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_09EBD0CC9160696B4F95A2CAE89ED71C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_09EBD0CC9160696B4F95A2CAE89ED71C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1ED25BCFE2168B004790A2CAE89EBBFB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1ED25BCFE2168B004790A2CAE89EBBFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_CA9AC81015DDC2FC3169A2CAE89E149B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55FB50A9CEAF28AF60C8A2CAE899C09B" xlink:to="loc_us-gaap_OperatingLeaseLiability_CA9AC81015DDC2FC3169A2CAE89E149B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/LeasedPropertiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A8BAF487FA566CDE2B57558B20859328" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4FA3ED0D4EA58762368555940C2DFC09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A8BAF487FA566CDE2B57558B20859328" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4FA3ED0D4EA58762368555940C2DFC09" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0E011D3F507DB1F30D305B0CFBA3F16F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0B0438353097CFA219695B0CFBA33C24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0E011D3F507DB1F30D305B0CFBA3F16F" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0B0438353097CFA219695B0CFBA33C24" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/NetLossPerSharePotentialDilutiveOutstandingSecuritiesExcludedFromDilutedNetLossPerCommonShareDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_C495553BD32D79B05D3C51507F8AEAB7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_A5F31AE7E735460E67C551507F8ADD30" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_C495553BD32D79B05D3C51507F8AEAB7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_A5F31AE7E735460E67C551507F8ADD30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_654A15EAD8614C64865E51507F8A5EAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_A5F31AE7E735460E67C551507F8ADD30" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_654A15EAD8614C64865E51507F8A5EAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_DEC83A89638BA53C6CDD51507F8B632A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_654A15EAD8614C64865E51507F8A5EAC" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_DEC83A89638BA53C6CDD51507F8B632A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_01255FC7C91B9183CB1351507F8B65A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_DEC83A89638BA53C6CDD51507F8B632A" xlink:to="loc_us-gaap_EmployeeStockOptionMember_01255FC7C91B9183CB1351507F8B65A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_F8FF28106EE0E5A8D6EB51507F8B530F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_DEC83A89638BA53C6CDD51507F8B632A" xlink:to="loc_us-gaap_WarrantMember_F8FF28106EE0E5A8D6EB51507F8B530F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B0F328129B771F7D176151507F8BA25B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_A5F31AE7E735460E67C551507F8ADD30" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B0F328129B771F7D176151507F8BA25B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_29798CE20C589852D4B951507F8C0398" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_B0F328129B771F7D176151507F8BA25B" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_29798CE20C589852D4B951507F8C0398" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_EE1117346B0D5EA3801B34AA4BF1FBF2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0EE9B21F09735D2491486977C42C2A06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_EE1117346B0D5EA3801B34AA4BF1FBF2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0EE9B21F09735D2491486977C42C2A06" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OrganizationAndDescriptionOfBusiness" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ABF70D8D0A85B6B9FE9427A5B2F6BD0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0CE9F1B1F68357CD9BDD1C5305FC6BF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7ABF70D8D0A85B6B9FE9427A5B2F6BD0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0CE9F1B1F68357CD9BDD1C5305FC6BF1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/OrganizationAndDescriptionOfBusinessAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_F8CBD3944FD315960B804AFD877E0F86" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_E6F622492E86E2EF34304AFD877F6297" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_F8CBD3944FD315960B804AFD877E0F86" xlink:to="loc_us-gaap_NumberOfOperatingSegments_E6F622492E86E2EF34304AFD877F6297" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_18E02A0E3A0390C91AFF5B0CFD3BB012" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_66D586C4FD1C123940795B0CFD3B80D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_18E02A0E3A0390C91AFF5B0CFD3BB012" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_66D586C4FD1C123940795B0CFD3B80D5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_F4478DFDFC47D5AD25009A5601BBDB4C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25A683F3ED379DEBFC3E9A5601BB4B53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_F4478DFDFC47D5AD25009A5601BBDB4C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25A683F3ED379DEBFC3E9A5601BB4B53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_48870CCDDB55825428849A5601BB2BB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25A683F3ED379DEBFC3E9A5601BB4B53" xlink:to="loc_us-gaap_PlanNameAxis_48870CCDDB55825428849A5601BB2BB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_593BB9E5B2A015DC9AA09A5601BB13C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_48870CCDDB55825428849A5601BB2BB7" xlink:to="loc_us-gaap_PlanNameDomain_593BB9E5B2A015DC9AA09A5601BB13C4" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_TwoThousandAndFifteenStockIncentivePlanMember" xlink:label="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_35D3C39ECC2840F652749A5601BB6815" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_593BB9E5B2A015DC9AA09A5601BB13C4" xlink:to="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_35D3C39ECC2840F652749A5601BB6815" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:label="loc_dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_459BAB6B343E1E39EC069A5601BB289D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_593BB9E5B2A015DC9AA09A5601BB13C4" xlink:to="loc_dare_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_459BAB6B343E1E39EC069A5601BB289D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_240E2E434E2C89A4EB4B9A5601BBEDB6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25A683F3ED379DEBFC3E9A5601BB4B53" xlink:to="loc_us-gaap_AwardTypeAxis_240E2E434E2C89A4EB4B9A5601BBEDB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_139E42EC4CA7A34D0A189A5601BBE29C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_240E2E434E2C89A4EB4B9A5601BBEDB6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_139E42EC4CA7A34D0A189A5601BBE29C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2F6055154DFD13FA3FA19A5601BB3874" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_139E42EC4CA7A34D0A189A5601BBE29C" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2F6055154DFD13FA3FA19A5601BB3874" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_22B1F453F634535B5F6D9A5601BBEA70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_139E42EC4CA7A34D0A189A5601BBE29C" xlink:to="loc_us-gaap_RestrictedStockMember_22B1F453F634535B5F6D9A5601BBEA70" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_4217EA82834CB80D25A39A5601BBC2E6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25A683F3ED379DEBFC3E9A5601BB4B53" xlink:to="loc_dei_LegalEntityAxis_4217EA82834CB80D25A39A5601BBC2E6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_ACE2091CE3A407297A639A5601BB1019" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4217EA82834CB80D25A39A5601BBC2E6" xlink:to="loc_dei_EntityDomain_ACE2091CE3A407297A639A5601BB1019" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PrivateDareMember" xlink:label="loc_dare_PrivateDareMember_078104A728AF77BAA2939A5601BB852F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ACE2091CE3A407297A639A5601BB1019" xlink:to="loc_dare_PrivateDareMember_078104A728AF77BAA2939A5601BB852F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_25A683F3ED379DEBFC3E9A5601BB4B53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_45FD996FCF17AC5EB0A49A5601BB7622" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_45FD996FCF17AC5EB0A49A5601BB7622" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_CF43963E2637D82475139A5601BBFC2A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_CF43963E2637D82475139A5601BBFC2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_22E2D28E31EED35999179A5601BB8ED5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_22E2D28E31EED35999179A5601BB8ED5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_EEE994B2C10CBD6737AD9A5601BB869E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_EEE994B2C10CBD6737AD9A5601BB869E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4BD30893B58BBCD31ABB9A5601BBFE29" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4BD30893B58BBCD31ABB9A5601BBFE29" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_OfferingPeriod" xlink:label="loc_dare_OfferingPeriod_9FB0BCD7BD8A0DAE83B29A5601BBD38A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_dare_OfferingPeriod_9FB0BCD7BD8A0DAE83B29A5601BBD38A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_B469C966899CB3DDAE989A5601BB87E8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_B469C966899CB3DDAE989A5601BB87E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7D5A95EECA1BBF6522DE9A5601BBB8C5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7D5A95EECA1BBF6522DE9A5601BBB8C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4C79DB18BAFDB9C7E8D89A5601BB0868" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4C79DB18BAFDB9C7E8D89A5601BB0868" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_679E315D7AFC0ECED3319A5601BBD58B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_679E315D7AFC0ECED3319A5601BBD58B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_9DC187901A1D38110D809A6EE7F997B6" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_9DC187901A1D38110D809A6EE7F997B6" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PeriodOfTerminationOfStockOptionsVestedAfterTerminationDate" xlink:label="loc_dare_PeriodOfTerminationOfStockOptionsVestedAfterTerminationDate_1CE2001FEDDDC23D0DD59A5601CB739D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_dare_PeriodOfTerminationOfStockOptionsVestedAfterTerminationDate_1CE2001FEDDDC23D0DD59A5601CB739D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UnamortizedFairValueExpenseInStockPurchaseTransaction" xlink:label="loc_dare_UnamortizedFairValueExpenseInStockPurchaseTransaction_DC867681B9F98682B0949A5601CB6549" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_dare_UnamortizedFairValueExpenseInStockPurchaseTransaction_DC867681B9F98682B0949A5601CB6549" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2BB48A3A6E3037F185429A5601CB6EC7" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2BB48A3A6E3037F185429A5601CB6EC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_A428667660A593200A5E9A5601CB637F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_A428667660A593200A5E9A5601CB637F" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WeightedAverageAmortizationPeriod" xlink:label="loc_dare_WeightedAverageAmortizationPeriod_6259CC02B14BEC3204FE9A5601CB8829" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_dare_WeightedAverageAmortizationPeriod_6259CC02B14BEC3204FE9A5601CB8829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_2CF1273DBD2CFE613F799A5601CB5726" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2E110B6DDE167FB722A29A5601BB9806" xlink:to="loc_us-gaap_CommonStockSharesIssued_2CF1273DBD2CFE613F799A5601CB5726" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryOfAssumptionsUsedInBlackScholesOptionPricingModelForStockOptionsGrantedToEmployeesAndDirectorsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_863B1DB00957354336AF51507FDC3C5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_863B1DB00957354336AF51507FDC3C5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_A315F35486D3CC7A787D51507FDCAFF8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_A315F35486D3CC7A787D51507FDCAFF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_FCE4F1390870D2BD510B51507FDCDA55" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_FCE4F1390870D2BD510B51507FDCDA55" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:label="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_FB72D966C540A0AC1FA951507FDC9B8C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:to="loc_dare_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_FB72D966C540A0AC1FA951507FDC9B8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_E97C4932FE6B27D49D8651507FDDC2E3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_E97C4932FE6B27D49D8651507FDDC2E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C0A9423F6C891813EEE251507FDD0D94" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BA9C81597991DD2F92ED51507FDB67E5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_C0A9423F6C891813EEE251507FDD0D94" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryOfRecognizedStockBasedCompensationExpenseRelatedToStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23403BA85CD99550464551507FE0FC28" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8DDEB45E6CB8974EEF1751507FE06CFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23403BA85CD99550464551507FE0FC28" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8DDEB45E6CB8974EEF1751507FE06CFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_B7FF42C1898AA5F554D751507FE0B421" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8DDEB45E6CB8974EEF1751507FE06CFD" xlink:to="loc_us-gaap_AwardTypeAxis_B7FF42C1898AA5F554D751507FE0B421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_987C1ED52C47C5238FD051507FE1688B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_B7FF42C1898AA5F554D751507FE0B421" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_987C1ED52C47C5238FD051507FE1688B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_EADFC24BC492ECCAA43A51507FE15C87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_987C1ED52C47C5238FD051507FE1688B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_EADFC24BC492ECCAA43A51507FE15C87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_660C9161C9051B9E94E551507FE19B01" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8DDEB45E6CB8974EEF1751507FE06CFD" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_660C9161C9051B9E94E551507FE19B01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_F84B87542D228B3C61CF51507FE1D584" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_660C9161C9051B9E94E551507FE19B01" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_F84B87542D228B3C61CF51507FE1D584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_D015CAA557C9FBEB6C0851507FE2BE04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F84B87542D228B3C61CF51507FE1D584" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_D015CAA557C9FBEB6C0851507FE2BE04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_50AAB4692214FEBAAEF651507FE2D66B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_F84B87542D228B3C61CF51507FE1D584" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_50AAB4692214FEBAAEF651507FE2D66B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_91E51F8F1EA945AC22EF51507FE271E7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8DDEB45E6CB8974EEF1751507FE06CFD" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_91E51F8F1EA945AC22EF51507FE271E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5E79B67084FA56C06A0651507FE2C39D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_91E51F8F1EA945AC22EF51507FE271E7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5E79B67084FA56C06A0651507FE2C39D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationSummaryOfStockOptionActivityForAmended2014PlanAndRelatedInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_D6DCB906B53BBE37001D9A56016DA0C4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1351860212A78057BB199A56016DE44F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_D6DCB906B53BBE37001D9A56016DA0C4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1351860212A78057BB199A56016DE44F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_4AE7E7134C1EEBB0FF419A56016D94C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1351860212A78057BB199A56016DE44F" xlink:to="loc_dei_LegalEntityAxis_4AE7E7134C1EEBB0FF419A56016D94C3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5559E8D22A53372A34069A56017DE2F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4AE7E7134C1EEBB0FF419A56016D94C3" xlink:to="loc_dei_EntityDomain_5559E8D22A53372A34069A56017DE2F1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PrivateDareMember" xlink:label="loc_dare_PrivateDareMember_FF5AE179D8D86A2385089A56017D2FDC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5559E8D22A53372A34069A56017DE2F1" xlink:to="loc_dare_PrivateDareMember_FF5AE179D8D86A2385089A56017D2FDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5E2B0D8020E9EAD2EE7E9A56017D7ED2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1351860212A78057BB199A56016DE44F" xlink:to="loc_us-gaap_PlanNameAxis_5E2B0D8020E9EAD2EE7E9A56017D7ED2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A63D6CF1F1EC078D76CF9A56017DA75E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5E2B0D8020E9EAD2EE7E9A56017D7ED2" xlink:to="loc_us-gaap_PlanNameDomain_A63D6CF1F1EC078D76CF9A56017DA75E" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_TwoThousandAndFifteenStockIncentivePlanMember" xlink:label="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_C900E1E039880E0362609A56017D0554" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_A63D6CF1F1EC078D76CF9A56017DA75E" xlink:to="loc_dare_TwoThousandAndFifteenStockIncentivePlanMember_C900E1E039880E0362609A56017D0554" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_19C1D5EF62C1AC2991169A56017D4137" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1351860212A78057BB199A56016DE44F" xlink:to="loc_us-gaap_AwardTypeAxis_19C1D5EF62C1AC2991169A56017D4137" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6AF109E71D367B80E76B9A56017DC2E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_19C1D5EF62C1AC2991169A56017D4137" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6AF109E71D367B80E76B9A56017DC2E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_D5577CB6D44DA99CD3919A56017DCD7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6AF109E71D367B80E76B9A56017DC2E0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_D5577CB6D44DA99CD3919A56017DCD7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5967506064B4192D93969A56017D7955" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1351860212A78057BB199A56016DE44F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5967506064B4192D93969A56017D7955" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5967506064B4192D93969A56017D7955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9D1A3E1EA36553F6D1319A56017DE49A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9D1A3E1EA36553F6D1319A56017DE49A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B6C403778928637A9589A56017DC04F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0B6C403778928637A9589A56017DC04F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2EC51878368BB058EFAB9A56017D988D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2EC51878368BB058EFAB9A56017D988D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1305F445BA73213A01B69A56017DEB5A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1305F445BA73213A01B69A56017DEB5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_8A7466BA7935ACD22BF29A751759F633" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_8A7466BA7935ACD22BF29A751759F633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_438B462FC43EF79A9D789A56017D2E8E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_438B462FC43EF79A9D789A56017D2E8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_BD1F3BCA2ED4F4237EFE9A56017D9EDD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84ECE9C2DC980E9E9B529A56017DAAA7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_BD1F3BCA2ED4F4237EFE9A56017D9EDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5967506064B4192D93969A56017D7955" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DE6099BA6D8920BC30949A56017DC80F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DE6099BA6D8920BC30949A56017DC80F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_202BC10C27B461A07C0C9A56017D0FBD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_202BC10C27B461A07C0C9A56017D0FBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_96A98856B81E76ED13F09A56017D8501" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_96A98856B81E76ED13F09A56017D8501" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_98C7ABDF36972D91169A9A56017D827D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_98C7ABDF36972D91169A9A56017D827D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1A2EC86558388032F9079A72FFD1C382" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1A2EC86558388032F9079A72FFD1C382" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E1E99C706E1003004D9A9A56017D860B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E1E99C706E1003004D9A9A56017D860B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_FC48EB33EF0AE075D1EF9A56017D5ADD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_D13CF58278C99867BCBA9A56017D35CC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_FC48EB33EF0AE075D1EF9A56017D5ADD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A409150C6BEB012DED9351508016D36C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_EF1CBE6C5DF2AE997A2C51508016A937" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A409150C6BEB012DED9351508016D36C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_EF1CBE6C5DF2AE997A2C51508016A937" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_90468317243DAE17ED18515080167C98" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A409150C6BEB012DED9351508016D36C" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_90468317243DAE17ED18515080167C98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_B3449CFDA6F4155D3C1351508017F697" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A409150C6BEB012DED9351508016D36C" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_B3449CFDA6F4155D3C1351508017F697" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_7C16DFD5FA72C95C53905B0CFC907294" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7FBDC5C72597ACF2265F5B0CFC90854B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7C16DFD5FA72C95C53905B0CFC907294" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7FBDC5C72597ACF2265F5B0CFC90854B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_2141024454A235A5A77B9A5600EF98CE" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_StockholdersEquityTable" xlink:label="loc_dare_StockholdersEquityTable_D5FB4A778DA18AE4ADA19A5600EFE79A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2141024454A235A5A77B9A5600EF98CE" xlink:to="loc_dare_StockholdersEquityTable_D5FB4A778DA18AE4ADA19A5600EFE79A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2D7794772D9A4AC4BA199A5600EF5B2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_D5FB4A778DA18AE4ADA19A5600EFE79A" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2D7794772D9A4AC4BA199A5600EF5B2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_B361BD59915A291B89139A5600EF53A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2D7794772D9A4AC4BA199A5600EF5B2F" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_B361BD59915A291B89139A5600EF53A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_6A1FC21ABEB14A46ACC99A5600EF5662" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_B361BD59915A291B89139A5600EF53A1" xlink:to="loc_us-gaap_OverAllotmentOptionMember_6A1FC21ABEB14A46ACC99A5600EF5662" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_628424DA475E7FB6D4AF9A5600EF44CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_D5FB4A778DA18AE4ADA19A5600EFE79A" xlink:to="loc_srt_RangeAxis_628424DA475E7FB6D4AF9A5600EF44CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_79130FE4DC635509FF319A5600EFA8EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_628424DA475E7FB6D4AF9A5600EF44CA" xlink:to="loc_srt_RangeMember_79130FE4DC635509FF319A5600EFA8EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_01346C7D7240156A82D89A5600EFE74B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_79130FE4DC635509FF319A5600EFA8EA" xlink:to="loc_srt_MaximumMember_01346C7D7240156A82D89A5600EFE74B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_2A6798B8C6D46559836B9A5600EFCFCE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_79130FE4DC635509FF319A5600EFA8EA" xlink:to="loc_srt_MinimumMember_2A6798B8C6D46559836B9A5600EFCFCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_61C89BEDF2C94C851A229A5600EFB274" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_D5FB4A778DA18AE4ADA19A5600EFE79A" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_61C89BEDF2C94C851A229A5600EFB274" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_B89E7282D1EA02C8186E9A5600EFFD3F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_61C89BEDF2C94C851A229A5600EFB274" xlink:to="loc_us-gaap_TypeOfAdoptionMember_B89E7282D1EA02C8186E9A5600EFFD3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201711Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201711Member_9D760536EB8FC07DCF069A5600EF36E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_B89E7282D1EA02C8186E9A5600EFFD3F" xlink:to="loc_us-gaap_AccountingStandardsUpdate201711Member_9D760536EB8FC07DCF069A5600EF36E3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_StockholdersEquityLineItems" xlink:label="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityTable_D5FB4A778DA18AE4ADA19A5600EFE79A" xlink:to="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_GrossProceedsFromIssuanceOfCommonStock" xlink:label="loc_dare_GrossProceedsFromIssuanceOfCommonStock_541328027702DD5EE6239A5600EF05CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_GrossProceedsFromIssuanceOfCommonStock_541328027702DD5EE6239A5600EF05CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_5ADE29BA86B30E6861F49A7935E98D18" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_5ADE29BA86B30E6861F49A7935E98D18" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PercentageOfAggregateCommission" xlink:label="loc_dare_PercentageOfAggregateCommission_BF2DD2B4C51E34B4E7369A5600EFF931" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_PercentageOfAggregateCommission_BF2DD2B4C51E34B4E7369A5600EFF931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_C0BA5D889889BF83490B9A5600EFA33A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_C0BA5D889889BF83490B9A5600EFA33A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_FAEC226EB9FBEC3B5BAE9A5600EFF9CF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_FAEC226EB9FBEC3B5BAE9A5600EFF9CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_E7D330FD81A0192E9B0A9A5600EFEBB8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_E7D330FD81A0192E9B0A9A5600EFEBB8" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UnderwritersOptionToPurchaseAdditionalSharesOfCommonStockPeriod" xlink:label="loc_dare_UnderwritersOptionToPurchaseAdditionalSharesOfCommonStockPeriod_1A5DE60B5CFF5634058F9A5600EF6F2D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_UnderwritersOptionToPurchaseAdditionalSharesOfCommonStockPeriod_1A5DE60B5CFF5634058F9A5600EF6F2D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_UnderwritersOptionToPurchaseAdditionalShares" xlink:label="loc_dare_UnderwritersOptionToPurchaseAdditionalShares_4D8B9CEBD2F80103B8F09A5600EF734B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_UnderwritersOptionToPurchaseAdditionalShares_4D8B9CEBD2F80103B8F09A5600EF734B" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_GrossProceedsFromOfferingOfCommonStockAndWarrants" xlink:label="loc_dare_GrossProceedsFromOfferingOfCommonStockAndWarrants_93CE12C38F7ED0A25BE79A5600EF94AD" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_GrossProceedsFromOfferingOfCommonStockAndWarrants_93CE12C38F7ED0A25BE79A5600EF94AD" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:label="loc_dare_ProceedsFromIssuanceOfCommonStockAndWarrants_449A0E02D5CFB2F9880E9A5600EFC91A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_ProceedsFromIssuanceOfCommonStockAndWarrants_449A0E02D5CFB2F9880E9A5600EFC91A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2F28D596560E4F3EEABB9A5600EFD71E" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2F28D596560E4F3EEABB9A5600EFD71E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_CD8B319B0A0BF83D7FC39A5600EF23B6" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_CD8B319B0A0BF83D7FC39A5600EF23B6" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_EstimatedFairValueOfWarrantsRecordedInEquity" xlink:label="loc_dare_EstimatedFairValueOfWarrantsRecordedInEquity_CAC3A74392D9D38EEAAA9A5600EF0D44" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_EstimatedFairValueOfWarrantsRecordedInEquity_CAC3A74392D9D38EEAAA9A5600EF0D44" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_NumberOfCommonStockWarrantsExercised" xlink:label="loc_dare_NumberOfCommonStockWarrantsExercised_6B4F64925C5653F79A259A5600EFC2D9" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_StockholdersEquityLineItems_4A2E34BE6DA14109EAF89A5600EF5089" xlink:to="loc_dare_NumberOfCommonStockWarrantsExercised_6B4F64925C5653F79A259A5600EFC2D9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityScheduleOfCommonStockWarrantsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_8F483D9ACCEF1FDB17925B1492982187" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_A4B2FE50196CD8364B815B0CFC4F801F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8F483D9ACCEF1FDB17925B1492982187" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_A4B2FE50196CD8364B815B0CFC4F801F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_638A0C5380FFC0218DBE5B0CFC4FF847" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_A4B2FE50196CD8364B815B0CFC4F801F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_638A0C5380FFC0218DBE5B0CFC4FF847" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_638A0C5380FFC0218DBE5B0CFC4FF847" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WarrantsExpiringOnDecemberOneTwoThousandTwentyOneMember" xlink:label="loc_dare_WarrantsExpiringOnDecemberOneTwoThousandTwentyOneMember_CCEF31083C2F69CD80D65B0CFC502B44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:to="loc_dare_WarrantsExpiringOnDecemberOneTwoThousandTwentyOneMember_CCEF31083C2F69CD80D65B0CFC502B44" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WarrantsExpiringOnDecemberSixTwoThousandTwentyOneMember" xlink:label="loc_dare_WarrantsExpiringOnDecemberSixTwoThousandTwentyOneMember_FB5C9D1CB208D7EC847F5B0CFC506F08" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:to="loc_dare_WarrantsExpiringOnDecemberSixTwoThousandTwentyOneMember_FB5C9D1CB208D7EC847F5B0CFC506F08" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WarrantsExpiringOnJanuaryEightTwoThousandTwentyMember" xlink:label="loc_dare_WarrantsExpiringOnJanuaryEightTwoThousandTwentyMember_5175FB11C7D510EA66C45B0CFC50D82D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:to="loc_dare_WarrantsExpiringOnJanuaryEightTwoThousandTwentyMember_5175FB11C7D510EA66C45B0CFC50D82D" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember" xlink:label="loc_dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember_EFE3C74B9A0EF3B9932F5B0CFC50F5D3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:to="loc_dare_WarrantsExpiringOnAprilFourTwoThousandTwentySixMember_EFE3C74B9A0EF3B9932F5B0CFC50F5D3" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember" xlink:label="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_8972636AA0D30E75F5FF5B0CFC51CC3E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_DA81431AFF8D0F1206675B0CFC5070FF" xlink:to="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_8972636AA0D30E75F5FF5B0CFC51CC3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_16C8F8FA3E48EF49B6505B0CFC51A569" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_A4B2FE50196CD8364B815B0CFC4F801F" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_16C8F8FA3E48EF49B6505B0CFC51A569" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_B2CD4683BC7C48017C725B0CFC51F957" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_16C8F8FA3E48EF49B6505B0CFC51A569" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_B2CD4683BC7C48017C725B0CFC51F957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6B942092455202FD598E5B0CFC580EC2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_16C8F8FA3E48EF49B6505B0CFC51A569" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6B942092455202FD598E5B0CFC580EC2" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_ClassOfWarrantOrRightsWarrantsExpirationDate" xlink:label="loc_dare_ClassOfWarrantOrRightsWarrantsExpirationDate_3741FE6E1A020B4CBB8D5B0CFC58658D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_16C8F8FA3E48EF49B6505B0CFC51A569" xlink:to="loc_dare_ClassOfWarrantOrRightsWarrantsExpirationDate_3741FE6E1A020B4CBB8D5B0CFC58658D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_58DCA4E773A95E7B9227ED870E76824C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_42269856E9815B36A4AC0BCA2E034E84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_58DCA4E773A95E7B9227ED870E76824C" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_42269856E9815B36A4AC0BCA2E034E84" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_A65A67242BF622CC15CF5B0CFB812436" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_4DF5037AFC7D0857ED5C5B0CFB81A036" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_A65A67242BF622CC15CF5B0CFB812436" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_4DF5037AFC7D0857ED5C5B0CFB81A036" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_969A5AF60BDF21150C789A55FF1FA347" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_A00D47F203A36B0C7B439A55FF1F22EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_969A5AF60BDF21150C789A55FF1FA347" xlink:to="loc_us-gaap_SubsequentEventTable_A00D47F203A36B0C7B439A55FF1F22EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_912266D0BFAAC4E9D2C29A55FF1F3C42" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_A00D47F203A36B0C7B439A55FF1F22EC" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_912266D0BFAAC4E9D2C29A55FF1F3C42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_F162273E6C6BA68D1B0C9A55FF21E228" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_912266D0BFAAC4E9D2C29A55FF1F3C42" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_F162273E6C6BA68D1B0C9A55FF21E228" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember" xlink:label="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_C33C495C12F4D87C890B9A55FF21B487" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_F162273E6C6BA68D1B0C9A55FF21E228" xlink:to="loc_dare_WarrantsExpiringOnFebruaryFifteenTwoThousandTwentyThreeMember_C33C495C12F4D87C890B9A55FF21B487" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_645A772483AE32EF357B9A55FF2214C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_A00D47F203A36B0C7B439A55FF1F22EC" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_645A772483AE32EF357B9A55FF2214C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_F7B531EA5A357FFF29039A55FF224B4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_645A772483AE32EF357B9A55FF2214C6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_F7B531EA5A357FFF29039A55FF224B4C" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PublicStockOfferingMember" xlink:label="loc_dare_PublicStockOfferingMember_A8FF6E2CCF7EDB2D57399A55FF22DD74" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_F7B531EA5A357FFF29039A55FF224B4C" xlink:to="loc_dare_PublicStockOfferingMember_A8FF6E2CCF7EDB2D57399A55FF22DD74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_A9DDC986A197CCC6AD6B9A55FF2226E1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_F7B531EA5A357FFF29039A55FF224B4C" xlink:to="loc_us-gaap_OverAllotmentOptionMember_A9DDC986A197CCC6AD6B9A55FF2226E1" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_PublicStockOfferingIncludingOverAllotmentOfSharesMember" xlink:label="loc_dare_PublicStockOfferingIncludingOverAllotmentOfSharesMember_C19133A2E23D4D3790FE9A55FF22E900" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_F7B531EA5A357FFF29039A55FF224B4C" xlink:to="loc_dare_PublicStockOfferingIncludingOverAllotmentOfSharesMember_C19133A2E23D4D3790FE9A55FF22E900" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_FC2F473B823399E439F89A55FF22FD25" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_A00D47F203A36B0C7B439A55FF1F22EC" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_FC2F473B823399E439F89A55FF22FD25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8CE836CD3355C069223F9A55FF22590C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_FC2F473B823399E439F89A55FF22FD25" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8CE836CD3355C069223F9A55FF22590C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_6236177671D2003C93649A55FF22BDD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8CE836CD3355C069223F9A55FF22590C" xlink:to="loc_us-gaap_SubsequentEventMember_6236177671D2003C93649A55FF22BDD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_A00D47F203A36B0C7B439A55FF1F22EC" xlink:to="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_E07D90359D3B2F5BD6779A55FF229C71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_E07D90359D3B2F5BD6779A55FF229C71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1BC98667892A513497549A55FF227BF1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1BC98667892A513497549A55FF227BF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_886995828302A43896A39A55FF225EB7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_886995828302A43896A39A55FF225EB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_36FD42EB216DB962DD6F9A55FF22C169" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_36FD42EB216DB962DD6F9A55FF22C169" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2A736DD6F9B3D560842C9A55FF26535A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2A736DD6F9B3D560842C9A55FF26535A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_C3C9FAC04200104FE9849A55FF26EE3D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0E63A6C63F07269864219A55FF225403" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_C3C9FAC04200104FE9849A55FF26EE3D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4FEEF8232E1E22EC210C5B0CFD70C1B8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2724CFFD36C2CCA2FD7D5B0CFD705BD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4FEEF8232E1E22EC210C5B0CFD70C1B8" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2724CFFD36C2CCA2FD7D5B0CFD705BD2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_063C4D0132B9EB441DD29A56022F952C" xlink:type="locator" />
    <link:loc xlink:href="dare-20190331.xsd#dare_SignificantAccountingPoliciesTable" xlink:label="loc_dare_SignificantAccountingPoliciesTable_93C23DDD43FA4A521FC89A56022F7A5D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_063C4D0132B9EB441DD29A56022F952C" xlink:to="loc_dare_SignificantAccountingPoliciesTable_93C23DDD43FA4A521FC89A56022F7A5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5CD7E0215C0D939117539A56022FE9CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_93C23DDD43FA4A521FC89A56022F7A5D" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5CD7E0215C0D939117539A56022FE9CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_004EED79203865698FDB9A56022F1DC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5CD7E0215C0D939117539A56022FE9CD" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_004EED79203865698FDB9A56022F1DC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E3ADFD332D5C8729B5279A56022F6093" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_004EED79203865698FDB9A56022F1DC0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_E3ADFD332D5C8729B5279A56022F6093" xlink:type="arc" />
    <link:loc xlink:href="dare-20190331.xsd#dare_SignificantAccountingPoliciesLineItems" xlink:label="loc_dare_SignificantAccountingPoliciesLineItems_D889DB9D3C168C07023B9A56022FB6F4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesTable_93C23DDD43FA4A521FC89A56022F7A5D" xlink:to="loc_dare_SignificantAccountingPoliciesLineItems_D889DB9D3C168C07023B9A56022FB6F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_75CC75E42D13BA9B5A639A56022FEC60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_D889DB9D3C168C07023B9A56022FB6F4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_75CC75E42D13BA9B5A639A56022FEC60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_E9DCD4DE6780D18E00819A56022F191E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_D889DB9D3C168C07023B9A56022FB6F4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_E9DCD4DE6780D18E00819A56022F191E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_2042DA67A159DE71733C9A56022F3AB6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dare_SignificantAccountingPoliciesLineItems_D889DB9D3C168C07023B9A56022FB6F4" xlink:to="loc_us-gaap_OperatingLeaseLiability_2042DA67A159DE71733C9A56022F3AB6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://darebioscience.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8D7834F378CB645A75F19A56023ECE7C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_A29C5FF6D290992C9BE09A56023E9ED8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8D7834F378CB645A75F19A56023ECE7C" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_A29C5FF6D290992C9BE09A56023E9ED8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_5AF23F50A920E8FC9DB19A56023E8B07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8D7834F378CB645A75F19A56023ECE7C" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_5AF23F50A920E8FC9DB19A56023E8B07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6327697B7B3E9F63FCFD9A56023E6BA9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8D7834F378CB645A75F19A56023ECE7C" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_6327697B7B3E9F63FCFD9A56023E6BA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_82A3B5CC4C999B4214329A56023EFD36" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8D7834F378CB645A75F19A56023ECE7C" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_82A3B5CC4C999B4214329A56023EFD36" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
